이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Indoor Overheating and Physiological Strain in Older Adults With COPD

2026년 10월 1일 업데이트: University of Ottawa

The Impact of Extreme Heat on Individuals Living With Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial of Day-Long Passive Indoor Heat Exposure

During warm weather, homes without air conditioning can stay hot for long periods, and most heat-related health problems in Canada happen indoors rather than outdoors. Health Canada recommends that indoor temperatures not exceed 26 °C in homes occupied by people who are more susceptible to heat. That recommendation is based largely on population-level evidence, and very little is known about how susceptible individuals actually respond, physiologically, when indoor temperatures rise above it.

Older adults living with chronic obstructive pulmonary disease (COPD) are among the groups identified as more susceptible to heat. COPD involves persistent airflow limitation, reduced lung and cardiovascular reserve, and altered cellular stress responses. Despite this, no laboratory study has directly measured how adults with COPD respond to a full day spent indoors in warm conditions.

This randomized crossover trial will measure how older adults with COPD respond to two different indoor environments, each experienced for eight hours on separate days at least one week apart. One day is spent at the recommended indoor temperature limit and the other at a warmer temperature representative of conditions recorded inside Canadian homes during hot weather. Participants remain seated and rest throughout; no exercise or work is performed.

Throughout each day, the research team continuously measures core body temperature, skin temperature, heart rate, and measures blood pressure, lung function, breathlessness, thermal comfort, cognitive performance, and balance at set time points. Blood and urine samples are collected at the start and end of each day. Participants are monitored continuously by trained staff.

The results are intended to strengthen the evidence base behind Canadian indoor temperature guidance and to inform recommendations for protecting people living with chronic lung disease during hot weather.

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

연구 유형

중재적

등록 (추정된)

18

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Ontario
      • Ottawa, Ontario, 캐나다, K1N 6N5

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

60년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Aged 60 to 80 years
  • Physician diagnosis of chronic obstructive pulmonary disease made at least 5 years previously
  • Clinically stable, with no acute exacerbation or active respiratory infection in the preceding 6 weeks
  • Current non-smoker
  • Able to communicate in English or French and to provide written informed consent

Exclusion Criteria:

  • Physical restriction preventing safe participation, including unstable cardiac or pulmonary disease, uncontrolled hypertension (resting blood pressure exceeding 150/95 mmHg), severe arthritis, renal impairment, active proliferative retinopathy, history of disabling stroke, or intermittent claudication
  • Recent change in medications judged by the investigators to make participation inadvisable
  • Cardiac abnormalities identified on electrocardiogram during the screening exercise test
  • Regular work or exercise in hot environments (heat acclimatized)

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Recommended indoor temperature limit (26 °C)

Eight-hour passive seated exposure to an indoor environment maintained at 26 °C and 45% relative humidity, corresponding to the recommended upper indoor temperature limit for heat-susceptible occupants.

Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting.

실험적: Indoor overheating (36 °C)

Eight-hour passive seated exposure to an indoor environment maintained at 36 °C and 45% relative humidity, representing warm indoor conditions recorded inside Canadian dwellings without mechanical cooling during heat events.

Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Core temperature (Peak)
기간: End of 8-hour exposure

Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the simulated indoor overheating exposure.

End of 8-hour exposure

2차 결과 측정

결과 측정
측정값 설명
기간
Profiles of Mood States (POMS)
기간: At the start (hour 0) and end of exposure (hour 8)

Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem-related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives. For each individual item, participants were asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) were summed to calculate its score.

At the start (hour 0) and end of exposure (hour 8)
Environmental Symptoms Questionnaire (ESQ)
기간: At the start (hour 0) and end of exposure (hour 8)

Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure [24, 25]. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score was calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake").

At the start (hour 0) and end of exposure (hour 8)
Orthostatic intolerance symptoms assessment
기간: At the start (hour 0) and end of exposure (hour 8)

Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the lying to standing tests. All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort".

At the start (hour 0) and end of exposure (hour 8)
Perceived arousal (Felt Arousal Scale)
기간: End of 8-hour exposure

Perceived arousal assessed using the Felt Arousal Scale, a single-item 6-point numerical rating scale on which participants respond to the question "How worked up are you?" Scores range from a minimum of 1 (low arousal) to a maximum of 6 (high arousal).

End of 8-hour exposure
Perceived thirst (Thirst Sensation Scale)
기간: End of 8-hour exposure

Perceived thirst assessed using the Thirst Sensation Scale, a single-item 9-point numerical rating scale on which participants respond to the question "How thirsty do you feel now?" Scores range from a minimum of 1 to a maximum of 9, with verbal anchors at 1 (not thirsty at all), 3 (a little thirsty), 5 (moderately thirsty), 7 (very thirsty), and 9 (very, very thirsty).

End of 8-hour exposure
Thermal sensation (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal sensation scale)
기간: End of 8-hour exposure

Thermal sensation assessed using the thermal sensation scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 7-point bipolar rating scale on which participants respond to the question "How do you feel right now?" Scores range from a minimum of -3 (cold) to a maximum of +3 (hot), with 0 indicating a neutral thermal sensation.

End of 8-hour exposure
Thermal comfort (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal comfort scale)
기간: End of 8-hour exposure

Thermal comfort assessed using the thermal comfort scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 4-point rating scale on which participants respond to the question "How comfortable do you feel right now?" Scores range from a minimum of 1 (comfortable) to a maximum of 4 (very uncomfortable).

End of 8-hour exposure
Change in plasma volume
기간: End of 8-hour exposure

Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill

End of 8-hour exposure
Fluid loss
기간: End of 8-hour exposure

Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption)

End of 8-hour exposure
Fluid consumption
기간: End of 8-hour exposure

Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

End of 8-hour exposure
Heart rate variability: RMSSD
기간: At the start (hour 0) and end of exposure (hour 8)

Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

At the start (hour 0) and end of exposure (hour 8)
Heart rate variability: SDNN
기간: At the start (hour 0) and end of exposure (hour 8)

Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

At the start (hour 0) and end of exposure (hour 8)
Rate pressure product
기간: End of 8-hour exposure

Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.

End of 8-hour exposure
Diastolic blood pressure
기간: End of 8-hour exposure

Diastolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

End of 8-hour exposure
Systolic blood pressure
기간: End of 8-hour exposure

Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

End of 8-hour exposure
Systolic Response to Standing From Supine
기간: At the start (hour 0) and end of exposure (hour 8)

Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of exposure (hour 8)
CDC 4-Stage Balance Test (Postural stability)
기간: At the start (hour 0) and end of exposure (hour 8)

To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).

At the start (hour 0) and end of exposure (hour 8)
Executive function (cognitive function)
기간: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of executive function. Participants will complete the Cued Stroop test, in which they are presented a sequence of congruent, neutral and incongruent colour-word tasks.

At the start (hour 0) and end of exposure (hour 8)
Memory recall (cognitive function)
기간: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.

At the start (hour 0) and end of exposure (hour 8)
Impulse control (cognitive function)
기간: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.

At the start (hour 0) and end of exposure (hour 8)
Reaction time (cognitive function)
기간: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue.

At the start (hour 0) and end of exposure (hour 8)
Cardiac response to standing from supine (30:15 Ratio)
기간: At the start (hour 0) and end of exposure (hour 8)

Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). Assessment is performed in the morning prior to and following daytime exposure.

At the start (hour 0) and end of exposure (hour 8)
Heart rate (AUC)
기간: End of 8-hour exposure

Area under the curve of heart rate (in bpm-hours)

End of 8-hour exposure
Heart rate (Peak)
기간: End of 8-hour exposure

Peak Heart rate (15-min average) during the 8-hour exposure

End of 8-hour exposure
Core temperature (AUC)
기간: End of 8-hour exposure

Area under the curve of rectal temperature (in degree-hours)

End of 8-hour exposure
Core temperature (hourly)
기간: Hourly during the 8-hour exposure

Rectal temperature measured at each hour of exposure (15-min average)

Hourly during the 8-hour exposure
Mean skin temperature (Peak)
기간: End of 8-hour exposure

Peak mean skin temperature (15-min average) during the 8-hour exposure

End of 8-hour exposure
Mean skin temperature (AUC)
기간: End of 8-hour exposure

Area under the curve of mean skin temperature (in degree-hours)

End of 8-hour exposure
Urine specific gravity
기간: At the start (hour 0) and end of exposure (hour 8)

Urine specific gravity measured by handheld refractometer

At the start (hour 0) and end of exposure (hour 8)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 연구 책임자: Glen P Kenny, PhD, University of Ottawa

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 10월 13일

기본 완료 (추정된)

2027년 5월 31일

연구 완료 (추정된)

2027년 5월 31일

연구 등록 날짜

최초 제출

2026년 9월 25일

QC 기준을 충족하는 최초 제출

2026년 9월 25일

처음 게시됨 (실제)

2026년 10월 1일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 10월 1일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • H-08-26-13258

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .